NCT00877734View on ClinicalTrials.gov

Efficacy and Tolerability of Baclofen for Alcohol Dependence

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

April 30, 2005

Primary Completion Date

May 31, 2007

Study Completion Date

June 30, 2007

Conditions
Alcohol Dependence
Interventions
DRUG

baclofen

10 mg Baclofen administered tid for 11 weeks

DRUG

placebo

Placebo administered tid for 11 weeks

BEHAVIORAL

BRENDA counseling

Trial Locations (1)

27599-7160

University of North Carolina at Chapel Hill School of Medicine, Chapel Hill

All Listed Sponsors
lead

University of North Carolina, Chapel Hill

OTHER

NCT00877734 - Efficacy and Tolerability of Baclofen for Alcohol Dependence | Biotech Hunter | Biotech Hunter